The Week Ahead: COS...
Health Care: Drugs
Idexx Laboratories (IDXX: NASDAQ)
$83.81 -0.67 | -0.79%
05/24/13 - 04:00 PM ET
Portfolios with IDXX
- Portfolio NameUser Type
- ContributorStocks Rising On Unusual Vo...
- ProRuane Cunniff
- ContributorPharmaceutical Short Squeez...
- ContributorStocks Rising On Unusual Vo...
- ContributorEarnings Season Short Squee...
- Contributor6 Health Care Stocks to Gai...
- Contributor10 Funds' Best Stocks to Be...
- ProChuck Royce - Royce & Assoc...
- ContributorUptrending Issue Short-Sque...
- UserMR's Retirement
Latest IDXX Headlines from TheStreet
- Idexx Rises On Unusually High Volume (IDXX) 04.25.13 | 04:04 pm
- Idexx Laboratories (IDXX): Today's Featured Health Care Laggard 04.23.13 | 05:04 pm
- Under-the-Radar Hot Industries For Small Business Profits 09.10.12 | 06:09 am
- Buy the 5 Pharma Stocks Everyone Hates 08.07.12 | 11:08 am
- IDEXX Laboratories' CEO Discusses Q2 2012 Results - Earnings Call Transcript 07.20.12 | 03:07 pm
- Idexx Stock Hits New 52-Week High (IDXX) 06.18.12 | 12:06 pm
- IDEXX Laboratories' CEO Hosts Annual Shareholder Meeting Conference (Transcript) 05.09.12 | 03:05 pm
- Idexx Reaches New 52-Week High (IDXX) 05.01.12 | 11:05 am
- IDEXX Laboratories' CEO Discusses Q1 2012 Results - Earnings Call Transcript 04.20.12 | 03:04 pm
- Idexx Reaches New 52-Week High (IDXX) 02.15.12 | 11:02 am
Press Releases for IDXX
- IDEXX Laboratories Announces Increase In Share Repurchase Program And Refinancing Of Revolving Credit Facility - PR Newswire 05.13.13 | 04:05 pm
- IDEXX Laboratories To Release 2013 First Quarter Financial Results - PR Newswire 04.08.13 | 04:04 pm
- IDEXX Laboratories Names Jeffrey Fiarman Executive Vice President And General Counsel - PR Newswire 04.04.13 | 04:04 pm
- IDEXX Laboratories Announces Federal Trade Commission Final Approval Of Consent Agreement - PR Newswire 02.12.13 | 11:02 am
- IDEXX Laboratories Announces CFO Merilee Raines To Retire In May 2013 - PR Newswire 01.16.13 | 04:01 pm
- IDEXX Laboratories To Release 2012 Fourth Quarter And Full-Year Financial Results - PR Newswire 01.14.13 | 04:01 pm
- IDEXX Laboratories To Present At J.P. Morgan Healthcare Conference - PR Newswire 01.02.13 | 02:01 pm
- IDEXX Laboratories Announces Federal Trade Commission Preliminary Approval Of Consent Agreement - PR Newswire 12.21.12 | 05:12 pm
- IDEXX Laboratories To Present At Piper Jaffray 24th Annual Healthcare Conference - PR Newswire 11.16.12 | 03:11 pm
- IDEXX Laboratories To Release 2012 Third Quarter Financial Results - PR Newswire 10.10.12 | 01:10 pm
Partner Headlines for IDXX
- Abaxis Expands Vet Product Line - Analyst Blog - NASDAQ 09.21.12 | 02:09 pm
- Abaxis Expands Vet Product Line - Analyst Blog - Zacks 09.21.12 | 10:09 am
- MWI Vet Remains Neutral - Analyst Blog - NASDAQ 09.12.12 | 07:09 pm
- MWI Vet-IDEXX Bond 'Non-Exclusive' - Analyst Blog - Zacks 08.10.12 | 04:08 pm
- Idexx Laboratories Earnings Call NUGGETS: End Markets Slowdown Throughout Q2, Europe Update - Wall St. Cheat Sheet 07.23.12 | 09:07 am
- UPDATE: Feltl Reiterates IDEXX Laboratories Hold, Increases PT to $90 - Benzinga 04.23.12 | 01:04 pm
- Little Known Dividend Stock That Could Double In 2012 - Seeking Alpha 03.02.12 | 08:03 am
- Bank of America Raises PO on IDEXX Laboratories to $91 - Benzinga 01.27.12 | 09:01 am
- Top Small-Cap Value Stocks By Chuck Royce - Seeking Alpha 12.15.11 | 07:12 am
- Abaxis Remains Neutral - Analyst Blog - Zacks 03.16.11 | 09:03 pm
